Home » Newsletters » BioWorld

BioWorld

April 13, 2000

View Archived Issues

Merz Shows Memantine Improves Cognition In Vascular Dementia

Exact Brings In $32M To Expand Screening For Colorectal Cancer

Other News To Note

Aphton Raises $16M Privately To Fund Phase III Cancer Study

Appointments And Advancements

Procyon Raises $14M Privately To Advance Oncology Drugs

Proteasomes Recycle Protein Rejects Into New Amino Acids, Tip Off Killer T Cells To Debris

Lorus Seeks $30M In Public Offering For Cancer Products

Myriad Genetics Withdraws Offering, Cites Market Forces

Axys Spins Out AAT For $60M Interest In Discovery Partners

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...